Ross Liao
YOU?
Author Swipe
View article: Artificial Intelligence–Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy
Artificial Intelligence–Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy Open
PURPOSE Artificial intelligence (AI) tools that identify pathologic features from digitized whole-slide images (WSIs) of prostate cancer (CaP) generate data to predict outcomes. The objective of this study was to evaluate the clinical vali…
View article: A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC)
A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC) Open
SCBC is an aggressive subtype of bladder cancer with high metastatic potential and few effective therapies. The defining mutations of neuroendocrine cancers include loss-of-function mutations in p53 and Rb and gain-of-function mutations in…
View article: Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution
Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution Open
Androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, and the development of castrate-resistant prostate cancer (CRPC) is the primary cause of prostate cancer-related mortality. While CRPC typically devel…
View article: Supplementary Tables S1-S2, Supplementary Figures S1-S5 from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance
Supplementary Tables S1-S2, Supplementary Figures S1-S5 from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance Open
Supplementary Table S1: siRNA and shRNA Vectors Supplementary Table S2: The sequence of primers used in this study Supplementary Figure S1. miR-21 suppresses PDCD4 expression in normal prostate epithelial cells. Supplementary Figure S2. An…
View article: Data from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance
Data from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance Open
Androgen receptor (AR) transcriptional activity contributes to prostate cancer development and castration resistance. The growth and survival pathways driven by AR remain incompletely defined. Here, we found PDCD4 to be a new target of AR …
View article: Supplementary Tables S1-S2, Supplementary Figures S1-S5 from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance
Supplementary Tables S1-S2, Supplementary Figures S1-S5 from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance Open
Supplementary Table S1: siRNA and shRNA Vectors Supplementary Table S2: The sequence of primers used in this study Supplementary Figure S1. miR-21 suppresses PDCD4 expression in normal prostate epithelial cells. Supplementary Figure S2. An…
View article: Data from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance
Data from PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance Open
Androgen receptor (AR) transcriptional activity contributes to prostate cancer development and castration resistance. The growth and survival pathways driven by AR remain incompletely defined. Here, we found PDCD4 to be a new target of AR …
View article: Contemporary Management of Bulbar Urethral Strictures.
Contemporary Management of Bulbar Urethral Strictures. Open
Urethral stricture disease (USD) is a progressive scar-forming disease commonly encountered by urologists and is challenging to manage. USD most frequently occurs in the bulbar urethra. Patients typically present with chronic obstructive v…
View article: MP50-09 BLADDER RECURRENCE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
MP50-09 BLADDER RECURRENCE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA Open
You have accessJournal of UrologyBladder Cancer: Upper Tract Transitional Cell Carcinoma I (MP50)1 Apr 2019MP50-09 BLADDER RECURRENCE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA Joseph Cheaib*, Ross Liao, Mohit Gupta, Max Kates, Mich…
View article: MP50-20 IMPLICATIONS OF DISCORDANT DIAGNOSTIC TO FINAL SURGICAL PATHOLOGY IN HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA
MP50-20 IMPLICATIONS OF DISCORDANT DIAGNOSTIC TO FINAL SURGICAL PATHOLOGY IN HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA Open
You have accessJournal of UrologyBladder Cancer: Upper Tract Transitional Cell Carcinoma I (MP50)1 Apr 2019MP50-20 IMPLICATIONS OF DISCORDANT DIAGNOSTIC TO FINAL SURGICAL PATHOLOGY IN HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA Joseph Chea…
View article: PD05-10 LOSS OF MIR-21 DELAYS MYC-DRIVEN PROSTATE CANCER PROGRESSION IN THE HI-MYC TRANSGENIC MOUSE MODEL
PD05-10 LOSS OF MIR-21 DELAYS MYC-DRIVEN PROSTATE CANCER PROGRESSION IN THE HI-MYC TRANSGENIC MOUSE MODEL Open
You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology I (PD05)1 Apr 2019PD05-10 LOSS OF MIR-21 DELAYS MYC-DRIVEN PROSTATE CANCER PROGRESSION IN THE HI-MYC TRANSGENIC MOUSE MODEL Kenji Zennami*, Fatima Rafiqi, R…
View article: Table of contents
Table of contents Open
On the CoverMRI (T1-weighted with gadolinium) showing enhancing, multilobulated mass in right middle cranial fossa with mass effect on the temporal lobe measuring 3.7 × 3.4 × 3.3cm.The mass also filled the right middle ear and EAC with sur…
View article: Interview date trends for dermatology residency from 2012-2017
Interview date trends for dermatology residency from 2012-2017 Open
Data regarding dermatology residency interview patterns can better inform applicants regarding the application process as well as encourage further coordination among programs. Our objective was to describe dermatology residency interview …
View article: PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance Open
Androgen receptor (AR) transcriptional activity contributes to prostate cancer development and castration resistance. The growth and survival pathways driven by AR remain incompletely defined. Here, we found PDCD4 to be a new target of AR …
View article: MP18-01 INCIDENCE OF LOWER PATHOLOGIC STAGE IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA
MP18-01 INCIDENCE OF LOWER PATHOLOGIC STAGE IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA Open
You have accessJournal of UrologyBladder Cancer: Upper Tract Transitional Cell Carcinoma I1 Apr 2018MP18-01 INCIDENCE OF LOWER PATHOLOGIC STAGE IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR HIGH-RISK UPPER TRACT UROTHELIAL CARCINOM…
View article: MP99-14 PDCD4 IS A CHECK POINT OF MIR-21 INDUCED CASTRATION RESISTANCE IN HUMAN PROSTATE CANCER
MP99-14 PDCD4 IS A CHECK POINT OF MIR-21 INDUCED CASTRATION RESISTANCE IN HUMAN PROSTATE CANCER Open
On multivariate analysis, preoperative PSA level and high nYAP intensity score were independent prognostic factors for BCR in patients with PCa treated with CHT.CONCLUSIONS: nYAP expression in residual cancer cells is a potential prognosti…